November 13, 2024—R3 Vascular Inc. recently announced that the FDA granted investigational device exemption (IDE) approval to initiate the company’s ELITE-BTK pivotal trial of Magnitude, its ...
Revascularization with endovascular therapy has become an accepted mainstay of treatment by most interventionists. However, the Achilles’ heel with all peripheral interventions remains long, calcified ...
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
As an alternative to manual compression for achieving hemostasis after coronary catheterization procedures, vascular closure devices (VCDs) have emerged with several advantages—and a few disadvantages ...
All arteriovenous access circuits, whether native vein or prosthetic graft, will inevitably fail due to the development of neointimal hyperplastic stenoses. These smooth muscle cell lesions obstruct ...
Anatomically, critical limb ischemia (CLI) is characterized by multilevel and multivessel disease (eg, aortoiliac, femoropopliteal [FP], and infrapopliteal [IP]), but fewer than 10% of CLI patients ...
Endovascular aortic aneurysm repair (EVAR) has become the first choice of treatment in patients with abdominal aortic aneurysms (AAAs) and suitable anatomy. Approximately 40% of the patients do not ...
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...